Atragin
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==Atragin==<StructureSection load='3K7L' size='500' side='right' caption='Atragin' scene=''> | ==Atragin==<StructureSection load='3K7L' size='500' side='right' caption='Atragin' scene=''> | ||
==Introduction== | ==Introduction== | ||
- | '''Atragin'' (MW 49.7 kDa and theoretical pI 8.6) is a Snake Venom MetalloProtease (SVMP) belonging to the ADAM/adamlysin/ reprolysin family and is found in the venom of the Naja Atra, or Chinese cobra <ref name=Guan>PMID: 19932752</ref>. It contains a metalloprotease domain (M),disintegrin-like domain(D), and cysteine-rich domain (C), making it a P-III SVMP | + | '''Atragin'' (MW 49.7 kDa and theoretical pI 8.6) is a Snake Venom MetalloProtease (SVMP) belonging to the ADAM/adamlysin/ reprolysin family and is found in the venom of the Naja Atra, or Chinese cobra <ref name=Guan>PMID: 19932752</ref>. It contains a metalloprotease domain (M),disintegrin-like domain(D), and cysteine-rich domain (C), making it a P-III SVMP <ref name=Fox>PMID: 15922769</ref>. When injected into the bloodstream, P-III SVMPs cause hemorrhagic effects, inhibit platelet formation and inhibit cell migration activity<ref name=Guan>PMID: 19932752</ref><ref name=Gutierrez>PMID: 11086214</ref>. These P-III SVMPs bear very close resemblance to mammalian ADAM (A Disintegrin And Metalloprotease) proteins, which also contain the MDC domain architecture <ref name=Igarashi>PMID: 17485084</ref>. The ADAMs are a group of around 40 transmembrane proteins that have been found so far in mammals, 19 of which genes are found in humans <ref name=Seals>PMID: 12514095</ref><ref name=White>PMID: 14519395</ref>. These proteins play a role in the production of cytokines and growth factors, such as ADAM 17 which releases tumor necrosis factor alpha (TNFa) as an immunomodulatory and pro-inflammatory cytokine <ref name=Moss>PMID: 9034191</ref>; and ADAM 9 which has been shown to be involved in the release of heparin-binding EGF, which inhibits the proliferation of neighboring cells <ref name=Raab>PMID: 12621152</ref>. ADAM proteins have also been shown to be involved with multiple human diseases today, including cancer, asthma, cardiac hypertrophy and SARS <ref name=Askaura>PMID: 11786904</ref><ref name=Haga>PMID: 18490652</ref><ref name=Van Eredewegh>PMID: 12110844</ref><ref name=Wu>PMID: 9199213</ref>. Unfortunately, the full structure of the ADAM proteins is not yet available and our current understanding of the ADAM structure is based primarily on viper P-III SVMPs<ref name=Igarashi>PMID: 17485084</ref><ref name=Muniz>PMID: 18831982</ref><ref name=Takeda>PMID: 16688218</ref><ref name=Takeda>PMID: 18060879</ref><ref name=Zhu>PMID: 19505434</ref> . Atragin, however, is an elapid P-III SVMP and provides more clues as to how the MDC domains work together. |
==Structure== | ==Structure== | ||
- | <scene name='Atragin/All_domains/1'>Atragin</scene> is a 63x52x67 Å protein that contains a Metalloprotease domain, Disintegrin-like domain, and a cysteine-rich domain<ref name=Guan>PMID: 19932752</ref>. The overall architecture of the protein gives a <scene name='Atragin/C-like_structre/1'>C-shaped</scene> structure that is similar to other P-III SVMPs such as VAP1 | + | <scene name='Atragin/All_domains/1'>Atragin</scene> is a 63x52x67 Å protein that contains a Metalloprotease domain, Disintegrin-like domain, and a cysteine-rich domain<ref name=Guan>PMID: 19932752</ref>. The overall architecture of the protein gives a <scene name='Atragin/C-like_structre/1'>C-shaped</scene> structure that is similar to other P-III SVMPs such as VAP1 <ref name=Takeda>PMID: 16688218</ref> in that the recognition site of the C domain faces the M domain’s catalytic cleft in a linear orientation, which means the target recognized by the C domain could be the same as the substrate catalyzed by M domain. This is a contrast to other P-III SVMPs which can have an I-shaped structure that contains a non-linear orientation between the C and M domains, in which the target recognized by the C domain can be different than the catalyzed substrate molecule <ref name=Guan>PMID: 19932752</ref>. |
'''Metalloprotease Domain '' | '''Metalloprotease Domain '' | ||
The Metalloprotease domain (M) consists of | The Metalloprotease domain (M) consists of | ||
- | <scene name='Atragin/M_domain/1'>six alpha-helixes and 5 beta-sheets</scene> and is a metalloendopeptidase. Every endometalloprotease contains a <scene name='Atragin/Metalloph-h/1'>HEXXHXXGXXH</scene> strain of residues needed for zinc and substrate binding for proteolysis. In Atragin, the binding sequence can be found from aa 341-351. The <scene name='Atragin/Zn/1'>zinc</scene> atom is ligated by the side chains of His341 and 345 on the a-helix, and this allows His 351 at the turn the be | + | <scene name='Atragin/M_domain/1'>six alpha-helixes and 5 beta-sheets</scene> and is a metalloendopeptidase. Every endometalloprotease contains a <scene name='Atragin/Metalloph-h/1'>HEXXHXXGXXH</scene> strain of residues needed for zinc and substrate binding for proteolysis. In Atragin, the binding sequence can be found from aa 341-351. The <scene name='Atragin/Zn/1'>zinc</scene> atom is ligated by the side chains of His341 and 345 on the a-helix, and this allows His 351 at the turn the be responsible for the catalytic reaction <ref name=Gomis-Ruth>PMID: 12746556</ref>. |
Line 15: | Line 15: | ||
'''Disintegrin-like Domain '' | '''Disintegrin-like Domain '' | ||
- | Following the M domain and a linker <scene name='Atragin/S-region/1'>S-region</scene>, is the <scene name='Atragin/D_arm_shoulder/1'>Disintegrin-like</scene>(D) domain. This domain is thought to play an important role in the relative orientation of the M and C domains in P-III SVMPs (Think back to C-shaped versus I-shaped). Atragin maintains the C-shaped arhcitexture as its D-shoulder domain has three disulfide bonds, and its D-arm domain conatins another 3 disulfide bonds, which is similar to other C-shaped proteins | + | Following the M domain and a linker <scene name='Atragin/S-region/1'>S-region</scene>, is the <scene name='Atragin/D_arm_shoulder/1'>Disintegrin-like</scene>(D) domain. This domain is thought to play an important role in the relative orientation of the M and C domains in P-III SVMPs (Think back to C-shaped versus I-shaped). Atragin maintains the C-shaped arhcitexture as its D-shoulder domain has three disulfide bonds, and its D-arm domain conatins another 3 disulfide bonds, which is similar to other C-shaped proteins <ref name=Igarashi>PMID: 17485084</ref><ref name=Takeda>PMID: 16688218</ref>. One <scene name='Atragin/D_arm_shoulder_ssbond/2'>disulfide bond</scene> also connects these two subdomains. |
The disulfide bond pattern in the D domain alters the orientations of the <scene name='Atragin/All_domains/1'>other domains</scene> in the ADAM/adamalysin/ reprolysins family <ref name=Guan>PMID: 19932752</ref>. The different orientations could explain some of the ADAM enzymatic processes, seeing as the different lengths or altering the disulfide pairs of the D-domain can increase or decrease the size of the cleft and the orientation. This could cause for substrates of different sizes and shapes to able to be cleaved by the M-domain in ADAMs <ref name=Guan>PMID: 19932752</ref>. | The disulfide bond pattern in the D domain alters the orientations of the <scene name='Atragin/All_domains/1'>other domains</scene> in the ADAM/adamalysin/ reprolysins family <ref name=Guan>PMID: 19932752</ref>. The different orientations could explain some of the ADAM enzymatic processes, seeing as the different lengths or altering the disulfide pairs of the D-domain can increase or decrease the size of the cleft and the orientation. This could cause for substrates of different sizes and shapes to able to be cleaved by the M-domain in ADAMs <ref name=Guan>PMID: 19932752</ref>. | ||
Line 21: | Line 21: | ||
'''Cysteine-rich Domain '' | '''Cysteine-rich Domain '' | ||
- | The Cysteine-rich (C) domain contains the <scene name='Atragin/C_wristahnd/1'>C-wrist and C-hand </scene>domains. The C-hand subdomain is the most intriguing to most researches because it contains the Hyper Variable Region (HVR<scene name='Atragin/Hvr/1'>Hyper Variable Region (HVR)</scene>. This region is through to play an important role in target selection since it sits on the inside of the C-shaped structures cleft | + | The Cysteine-rich (C) domain contains the <scene name='Atragin/C_wristahnd/1'>C-wrist and C-hand </scene>domains. The C-hand subdomain is the most intriguing to most researches because it contains the Hyper Variable Region (HVR<scene name='Atragin/Hvr/1'>Hyper Variable Region (HVR)</scene>. This region is through to play an important role in target selection since it sits on the inside of the C-shaped structures cleft <ref name=Takeda>PMID: 16688218</ref>. The C domain of Atragin consists of seven <scene name='Atragin/C_ssbonds/1'>disulfide bonds</scene>, and this suggests it may play a functional role. The HVR of Atragin is also though to be responsible for the inhibitory affect on cell migration activity <ref name=Guan>PMID: 19932752</ref>. |
</StructureSection> | </StructureSection> |
Revision as of 23:11, 1 December 2011
==Atragin==
|